ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy. - Wikidata - awgldk - TriplyDB

ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy.

ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy.

http://www.wikidata.org/entity/Q36666911

about

The kallikrein-kinin system in diabetic nephropathy Developments in renal pharmacogenomics and applications in chronic kidney disease ACE insertion/deletion (I/D) polymorphism and diabetic nephropathy.CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseases.Hypokalemia, its contributing factors and renal outcomes in patients with chronic kidney disease.Do genetic variants of the Renin-Angiotensin system predict blood pressure response to Renin-Angiotensin system-blocking drugs?: a systematic review of pharmacogenomics in the Renin-Angiotensin system Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies.Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine.Genomics in CKD: Is This the Path Forward?Can ADAMTS13 lead us to the paradise of personalized medicine?Novel drugs and intervention strategies for the treatment of chronic kidney disease.Genetic variant of the Renin-Angiotensin system and diabetes influences blood pressure response to Angiotensin receptor blockers.Significance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease.Regulation of urinary ACE2 in diabetic mice Genetic polymorphisms related to the renin-angiotensin-aldosterone system and response to antihypertensive drugs.Application of direct renin inhibition to chronic kidney disease.Renin-angiotensin system blocking drugs.ACE insertion/deletion polymorphism and diabetic nephropathy: clinical implications of genetic information.Identifying Common Genetic Risk Factors of Diabetic Neuropathies.Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2.Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitus.The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis.Angiotensin converting enzyme gene polymorphism in type II diabetics with nephropathy.Renin-angiotensin-aldosterone system blockade and urinary albumin excretion in community-based patients with Type 2 diabetes: the Fremantle Diabetes Study.Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms.Association between polymorphisms of the renin-angiotensin system and coronary artery disease in Chinese patients with type 2 diabetes.The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan.Variability in response to albuminuria-lowering drugs: true or random?Intervention using vitamin D for elevated urinary albumin in type 2 diabetes mellitus (IDEAL-2 Study): study protocol for a randomised controlled trial.

P2860

Q26827473-70FD294C-33FD-4E83-97D1-1BBBCA5E3D9B Q26999279-66BDF182-61B6-4547-9BFE-FCBFBBE815DF Q30486653-AC27D683-1904-4B19-9F4E-6BFCC5B27226 Q33984240-2DCFF1FA-3EE4-4CF4-95FA-F403D22C042C Q34812460-C6228127-F2A6-4045-8A74-EE236C80B933 Q35230775-5E33D087-48B9-4CBA-BDAD-8998C8F1B612 Q36063285-4819BA44-6C0E-4264-AB89-723A2D5F529C Q36285918-9FFD0223-A3ED-48BC-B466-B8A3655C351D Q36696625-84785A05-6042-4317-8F57-B127088EE449 Q37193270-DCEDEF57-19D8-4707-9454-2C2B9EBA5F97 Q37219043-5003953A-2424-4461-9BF0-106218BCD8D5 Q37269523-DBDADF04-E84C-4856-B064-D94DC8B0209F Q37416129-B1A910E4-2098-4455-B087-710A30C360A1 Q37476622-1BCE1CDE-CA52-451F-9AFF-3433AE433F13 Q37681549-3417B9C6-DC49-4C71-8166-6BCD3384D441 Q37758534-9C0C49D6-41EC-4D3D-8A40-1D4B12F766DC Q38137851-C5B5EE9A-BA93-45A3-A6A3-FCE1A34037F1 Q38317953-CC6D4821-C207-4ACB-9446-E42F041EB1A9 Q38527798-12EC2A66-5F9D-447B-B36A-3F9A4CCFDEC4 Q38895396-9ACB604D-728A-47CE-AD17-1DB79E2587A1 Q39631863-B94193F1-0327-4DE7-A725-AE71D3554376 Q40579516-D1A0F8BB-46F1-4B55-962F-512A80F6FED1 Q40728439-3AE18515-0037-4D65-8DE9-69257D40CB57 Q44474346-E5D6F710-01AD-4AC8-AC31-BE4AFAF971EC Q51158549-9BBE0DA3-4E1D-4CB2-ABF3-AAEA9048342B Q51359228-98E96A62-5328-480B-B60A-4CBE8373AA86 Q51496563-E5881154-D610-41F6-A039-400A3DB0836E Q55140376-C093D06A-342C-457C-9CCB-4492318E5A7C Q55279033-A7AD5783-7732-49A0-A6FA-14B59392CF98

P2860

ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy.

http://www.wikidata.org/entity/Q36666911

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

ACE gene polymorphism and losa ...... tic patients with nephropathy.

@ast

ACE gene polymorphism and losa ...... tic patients with nephropathy.

@en

type

label

ACE gene polymorphism and losa ...... tic patients with nephropathy.

@ast

ACE gene polymorphism and losa ...... tic patients with nephropathy.

@en

prefLabel

ACE gene polymorphism and losa ...... tic patients with nephropathy.

@ast

ACE gene polymorphism and losa ...... tic patients with nephropathy.

@en

P1433

Q36666911-2BD60E2B-2172-4753-82AA-438285D55438

P1476

Q36666911-65B33BDF-D43D-4FF2-ACAA-4EB10224E0B0

P2093

Q36666911-0ED5DCE2-EC07-48B1-81ED-EAB7D8E5E653

Q36666911-554F54FE-5F6A-4C36-969F-2C0FC2AA0223

Q36666911-5D98206A-D9A0-425A-86CC-DBEBC308EA84

Q36666911-7246FF83-E32E-4C7F-87AB-8C502037AD94

Q36666911-73172D88-ADF6-4606-B6BD-1B987F90A068

Q36666911-9E253479-016E-4EE6-96AE-D55493949739

Q36666911-A1C59DDA-0B29-46B8-A2C5-7D69C6566967

Q36666911-C6A331AA-F353-4CA9-8A7D-04F932F1A3A6

Q36666911-FC1AC2E0-67D6-4804-98F4-6FF68D230B88

P2860

Q36666911-0E56CCC8-71EE-441C-AF1B-18EE0BB961BB

Q36666911-1E008176-45A3-45D1-A118-9FA6C3D2B3E1

Q36666911-1FDCD5B0-3BF3-4943-B6C7-4DA829D6C59D

Q36666911-269838AD-E426-485B-A30F-CEF0E4AF2495

Q36666911-290AF300-959B-44A6-9C83-FD610166D7F1

Q36666911-497368DD-3FC3-4EA2-BCF3-74F525CB3E9C

Q36666911-4AC932BC-DB77-467E-87B6-03CAA79BB889

Q36666911-5270C38A-96E0-465E-9AFA-580B14AD16CD

Q36666911-5CDD5EA9-6080-4104-B45F-958DDC9A4858

Q36666911-6486DC35-9E3A-4512-84E0-1546340B82D4

P304

Q36666911-28B3A9EF-DD47-4888-A805-905FEE92B8CB

P31

Q36666911-03C26D23-26AC-4A50-8841-09FE9F194AF8

P356

Q36666911-0D0D947E-AD1A-4C43-A267-784512B2A1BA

P433

Q36666911-6DE03D8B-FEF5-47A9-BD4E-9C4C81388C94

P478

Q36666911-4A561B56-B4C2-48FB-8C7B-7B3AF787EC79

P50

Q36666911-C638FCC4-3270-4248-9004-BFE6CE9058C2

Q36666911-D9839D2A-B261-4157-91BD-A8E1E93DDAF9

P577

Q36666911-AB6FC49B-418D-4606-A4DB-9064CD75D021

P5875

Q36666911-4BF30B51-C9E1-422B-8B60-F19C5C493C00

P698

Q36666911-A879BDD3-A31E-4F11-9AE9-D4727AA0F80F

P932

Q36666911-B438A9DE-C126-42E7-9D72-A52756CB14FA

P356

P1433

Journal of the American Society of Nephrology

P1476

ACE gene polymorphism and losa ...... tic patients with nephropathy.

@en

P2093

Barry M Brenner

http://www.w3.org/2001/XMLSchema#string

Dick de Zeeuw

http://www.w3.org/2001/XMLSchema#string

Hans-Henrik Parving

http://www.w3.org/2001/XMLSchema#string

Jared Lunceford

http://www.w3.org/2001/XMLSchema#string

Mark E Cooper

http://www.w3.org/2001/XMLSchema#string

Nancy Liu

http://www.w3.org/2001/XMLSchema#string

Paulette A Lyle

http://www.w3.org/2001/XMLSchema#string

Peggy H Wong

http://www.w3.org/2001/XMLSchema#string

Shahnaz Shahinfar

http://www.w3.org/2001/XMLSchema#string

P2860

Does the Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism modify the response to ACE inhibitor therapy?--A systematic review.

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Inheritance and drug response.

Pharmacogenomics--drug disposition, drug targets, and side effects.

An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.

Preventing end stage renal disease in diabetic patients--genetic aspect (part I).

Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study

Genetic variation in the Renin-Angiotensin system and progression of diabetic nephropathy.

Enhanced responses of blood pressure, renal function, and aldosterone to angiotensin I in the DD genotype are blunted by low sodium intake.

Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL.

P304

771-779

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2007050582

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Remuzzi

P577

2008-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5651331

http://www.w3.org/2001/XMLSchema#string

P698

18199798

http://www.w3.org/2001/XMLSchema#string

P932

2390973

http://www.w3.org/2001/XMLSchema#string